Second primary malignancies in multiple myeloma: an overview and IMWG consensus

Background. Therapeutic advancements following the introduction of autologous stem cell transplantation and ‘novel’ agents have significantly improved clinical

Saved in:
Bibliographic Details
Main Authors: Musto, Pellegrino (Author) , Hillengaß, Jens (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: Annals of oncology
Year: 2016, Volume: 28, Issue: 2, Pages: 228-245
ISSN:1569-8041
DOI:10.1093/annonc/mdw606
Online Access:Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdw606
Get full text
Author Notes:P. Musto, K.C. Anderson, M. Attal, P.G. Richardson, A. Badros, J. Hou, R. Comenzo, J. Du, B.G.M. Durie, J. San Miguel, H. Einsele, W.M. Chen, L. Garderet, G. Pietrantuono, J. Hillengass, R.A. Kyle, P. Moreau, J.J. Lahuerta, O. Landgren, H. Ludwig, A. Larocca, A. Mahindra, M. Cavo, A. Mazumder, P.L. McCarthy, A. Nouel, S.V. Rajkumar, A. Reiman, E. Riva, O. Sezer, E. Terpos, I. Turesson, S. Usmani, B.M. Weiss, A. Palumbo
Description
Summary:Background. Therapeutic advancements following the introduction of autologous stem cell transplantation and ‘novel’ agents have significantly improved clinical
Item Description: Published: 17 November 2016
Gesehen am 30.08.2018
Physical Description:Online Resource
ISSN:1569-8041
DOI:10.1093/annonc/mdw606